60 Degrees Pharmaceuticals, Inc Common Stock
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $230 | $135 | $125 | $146 |
Gross Profit | 112 | 23 | 36 | 80 |
EBITDA | -2,032 | -2,144 | -4,159 | 451 |
EBIT | -2,048 | -2,158 | -4,170 | 429 |
Net Income | -2,045 | -2,159 | -4,172 | 430 |
Net Change In Cash | 230 | 135 | 125 | 146 |
Free Cash Flow | -1,640 | -1,719 | -1,318 | -1,150 |
Cash | 1,659 | 3,300 | 1,576 | 2,894 |
Basic Shares | 879 | 2,443 | 1,014 | 10,124 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $607 | $253 | $223 | $1,160 |
Gross Profit | 222 | -220 | -209 | 309 |
EBITDA | -7,883 | -1,426 | -2,109 | -1,014 |
EBIT | -7,947 | -1,526 | -2,187 | -1,086 |
Net Income | -7,947 | -3,765 | -6,181 | -4,251 |
Net Change In Cash | 607 | 253 | 223 | 1,160 |
Free Cash Flow | -5,829 | -4,658 | -1,070 | -684 |
Cash | 1,659 | 2,142 | 264 | 115 |
Basic Shares | 454 | 3,960 | 5,781 | 5,781 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$8.48 |
2024-09-30 | -$4.33 |
2024-06-30 | -$20.55 |
2024-03-31 | $0.03 |
